Form4insider filings, from the source

Company · CIK 0000887359 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Vericel Corp · VCEL

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $3.6M · 10net −$3.6M
$10k$10k$100k$100k$1M$1M$10M$10MbuyssalesMar 28Apr 27May 28Jun 28Jul 29Aug 28Sep 28

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 12, 2026 SForm 4 →Aug 14, 4:05 pm EDTKevin F McLaughlinDirector7,000$44.53$311,71018,300−27.7%10b5-1
Aug 12, 2026 MForm 4 →Aug 14, 4:05 pm EDTKevin F McLaughlinDirector7,000$13.05$91,35025,300—10b5-1
Aug 3, 2026 SForm 4 →Aug 5, 4:05 pm EDTMichael HalpinChief Operating Officer10,000$46.84$468,40016,394−37.9%10b5-1
Aug 3, 2026 MForm 4 →Aug 5, 4:05 pm EDTMichael HalpinChief Operating Officer10,000$16.66$166,60026,394—10b5-1
Jul 30, 2026 SForm 4 →Jul 31, 4:05 pm EDTJonathan SiegalPrincipal Accounting Officer4,500$48.90$220,0501,078−80.7%10b5-1
Jul 30, 2026 MForm 4 →Jul 31, 4:05 pm EDTJonathan SiegalPrincipal Accounting Officer4,500$31.51$141,8101,578—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:05 pm EDTJonathan SiegalPrincipal Accounting Officer2,500$29.82$74,5503,386—10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 4:05 pm EDTJonathan SiegalPrincipal Accounting Officer2,732$44.90$122,667886−75.5%10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 4:05 pm EDTJoseph Anthony Mara Jr.Chief Financial Officer5,000$44.75$223,75016,009−23.8%10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 4:05 pm EDTJonathan Mark HopperChief Medical Officer10,000$45.00$450,00075,753−11.7%10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:05 pm EDTJonathan Mark HopperChief Medical Officer10,000$29.82$298,20080,753—10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 4:05 pm EDTSean C. FlynnChief Legal Officer15,000$45.64$684,6001,647−90.1%10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:05 pm EDTSean C. FlynnChief Legal Officer15,000$16.25$243,75016,647—10b5-1
Jun 18, 2026 SForm 4 →Jun 22, 4:05 pm EDTMichael HalpinChief Operating Officer10,000$40.24$402,40016,248−38.1%10b5-1
Jun 18, 2026 MForm 4 →Jun 22, 4:05 pm EDTMichael HalpinChief Operating Officer10,000$16.66$166,60026,248—10b5-1
Jun 18, 2026 SForm 4 →Jun 22, 4:05 pm EDTSean C. FlynnChief Legal Officer15,000$40.21$603,1501,647−90.1%10b5-1
Jun 18, 2026 MForm 4 →Jun 22, 4:05 pm EDTSean C. FlynnChief Legal Officer15,000$16.25$243,75016,647—10b5-1
Jun 2, 2026 SForm 4 →Jun 4, 4:05 pm EDTJonathan Mark HopperChief Medical Officer4,375$35.00$153,12575,753−5.46%10b5-1
Jun 2, 2026 MForm 4 →Jun 4, 4:05 pm EDTJonathan Mark HopperChief Medical Officer4,375$16.66$72,88880,128—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 12, 2026 MForm 4 →Aug 14, 4:05 pm EDTKevin F McLaughlinDirector7,000——7,000—10b5-1
Aug 3, 2026 MForm 4 →Aug 5, 4:05 pm EDTMichael HalpinChief Operating Officer10,000——26,250—10b5-1
Jul 30, 2026 MForm 4 →Jul 31, 4:05 pm EDTJonathan SiegalPrincipal Accounting Officer4,500——3,500—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:05 pm EDTJonathan SiegalPrincipal Accounting Officer2,500——6,500—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:05 pm EDTJonathan Mark HopperChief Medical Officer10,000——20,000—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:05 pm EDTSean C. FlynnChief Legal Officer15,000——55,000—10b5-1
Jun 18, 2026 MForm 4 →Jun 22, 4:05 pm EDTMichael HalpinChief Operating Officer10,000——36,250—10b5-1
Jun 18, 2026 MForm 4 →Jun 22, 4:05 pm EDTSean C. FlynnChief Legal Officer15,000——70,000—10b5-1
Jun 2, 2026 MForm 4 →Jun 4, 4:05 pm EDTJonathan Mark HopperChief Medical Officer4,375——1,625—10b5-1